- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Effectiveness of perioperarive management of hepatectomised patients in biliary disease with Japanese Kampo medicine in terms of residual liver circulation
-
- Kaiho Takashi
- Department of Surgery, Kimitsu Chuo Hospital
-
- Shinmura Kazuyasu
- Department of Surgery, Kimitsu Chuo Hospital
-
- Nishimura Masaki
- Department of Surgery, Kimitsu Chuo Hospital
-
- Fujimoto Tatsuya
- Department of Gastroenterology, Kimitsu Chuo Hospital
Bibliographic Information
- Other Title
-
- 胆道疾患肝切除時における漢方製剤を用いた周術期管理の有用性
Search this article
Description
Hepatectomy in biliary disease, such as hilar bile duct carcinoma or gallbladder carcinoma, sometimes cause postoperative hyperbilirubinemia or hepatic failure because of lack of large hepatic parenchyma. We have used Japanese Kampo medicine, Dai-kenchu-to (TU-100) and/or Inchin-ko-to (TU-135), for perioperative management of hepatectomised patients. We estimated effectiveness of combined use of TU-100 and TU-135 in hepatectomised patients with biliary disease from the view point of residual liver circulation. We divided hepatectomised patients with biliary disease into three groups retrospectively, Group A (Control group, n=16), Group B (TU-100, n=9), Group C (TU-100 and TU-135, n=17). Although preoperative KICG in group C shows significantly low level compared to that in group A, there are no significant difference in patient's background, such as age, gender, preoperative hepatic function, parenchymal hepatic resection rate, operative time, amount of intraoperative bleeding. Ratio of KICG on one week after operation to estimated postoperative KICG are 121.3±36.1 in group A, 119.6±23.7 in group B, 161.7±76.1 in group C. Group C shows significantly higher ratio than Group A (p<0.05). A combination use of TU-100 and TU-135 for hepatectomised patients with biliary disease possibly increased residual liver KICG, which indicates improvement of liver micro-circulation.
Journal
-
- Tando
-
Tando 29 (2), 206-213, 2015
Japan Biliary Association
- Tweet
Details 詳細情報について
-
- CRID
- 1390001204347563520
-
- NII Article ID
- 130005078000
-
- ISSN
- 18836879
- 09140077
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed